on May 23, 2002
Published online before print May 23, 2002, doi: 10.1161/01.ATV.0000022878.37277.EC
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on October 3, 2001
Accepted on April 21, 2002
Role of Src Homology 2--Containing Tyrosine Phosphatase 2 on Proliferation of Rat Smooth Muscle Cells
Naoto Seki ;
From the Department of Clinical Cell Biology (N.S., N.H., Y. Suzuki, S.M., K.A., Y. Saito) and the Department of Applied Translational Research (N.H., K.A.), Graduate School of Medicine, Chiba University, Chiba, Japan.
* To whom correspondence should be addressed. E-mail: naohasi{at}intmed02.m.chiba-u.ac.jp.
Objective—Src homology 2--containing phosphotyrosine phosphatase 2 (SHP2) is ubiquitously expressed and believed to function as part of a positive signaling pathway mediating growth factor--induced protein tyrosine phosphorylation. Proliferation of aortic vascular smooth muscle cells (SMCs) is an important contributor to atherosclerosis. We examined the effect of SHP2 expression on SMC proliferative activity.
Methods and Results—SHP2 was abundant in cultured aortic SMCs, and SHP2 staining was markedly increased in the thickened aortic intima in rats with balloon-induced injury. We obtained several SMC clones by using geneticin screening. Endogenous SHP2 expression varied among individual clones. Significant positive relationships were observed between SHP2 expression and bromodeoxyuridine uptake in SMCs stimulated by FBS, platelet-derived growth factor, or insulin-like growth factor-1. In SMCs transiently transfected with SHP2, FBS stimulation significantly increased bromodeoxyuridine uptake beyond the uptake by control SMCs.
Conclusions—Increased SHP2 expression in SMCs may accelerate aortic atherosclerosis by increasing cell growth.
Key words: src homology 2--containing phosphotyrosine phosphatase 2 • smooth muscle cells • aorta • balloon injury • intima • media • atherosclerosis
This article has been cited by other articles:
 |
|
 |
|
  K. Kimura and S. Eguchi Angiotensin II type-1 receptor regulates RhoA and Rho-kinase/ROCK activation via multiple mechanisms. Focus on "Angiotensin II induces RhoA activation through SHP2-dependent dephosphorylation of the RhoGAP p190A in vascular smooth muscle cells" Am J Physiol Cell Physiol, November 1, 2009; 297(5): C1059 - C1061. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kappert, K. G. Peters, F. D. Bohmer, and A. Ostman Tyrosine phosphatases in vessel wall signaling Cardiovasc Res, February 15, 2005; 65(3): 587 - 598. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Dixit, D. Zhuang, B. Ceacareanu, and A. Hassid Treatment With Insulin Uncovers the Motogenic Capacity of Nitric Oxide in Aortic Smooth Muscle Cells: Dependence on Gab1 and Gab1-SHP2 Association Circ. Res., November 14, 2003; 93 (10): e113 - e123. [Abstract] [Full Text] [PDF]
|
|